Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
81
Views
7
CrossRef citations to date
0
Altmetric
Original Research

The Prognostic Significance of Preoperative Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Operated for Non-Small Cell Lung Cancer

Mariusz Łochowski1 Clinic of Thoracic Surgery and Respiratory Rehabilitation, Medical University of Lodz, Lodz, PolandCorrespondence[email protected]
,
Justyna Chałubińska-Fendler2 Department of Radiotherapy, Military Institute of Medicine, Warsaw, PolandORCID Iconhttps://orcid.org/0000-0002-4886-7565
ORCID Icon,
Izabela Zawadzka3 “Synevo” Medical Laboratory, Regional Multi-Specialist Center for Oncology and Traumatology of the Nicolaus Copernicus Memorial Hospital in Lodz, Lodz, Poland
,
Barbara Łochowska4 Department of Radiotherapy and General Oncology, Regional Multi-Specialist Center for Oncology and Traumatology of the Nicolaus Copernicus Memorial Hospital in Lodz, Lodz, Poland
,
Marek Rębowski1 Clinic of Thoracic Surgery and Respiratory Rehabilitation, Medical University of Lodz, Lodz, Poland
,
Daniel Brzeziński1 Clinic of Thoracic Surgery and Respiratory Rehabilitation, Medical University of Lodz, Lodz, Poland
&
Józef Kozak1 Clinic of Thoracic Surgery and Respiratory Rehabilitation, Medical University of Lodz, Lodz, Poland
 show all
Pages 7795-7802 | Published online: 09 Oct 2021

References

  • de Grot PM, Wu CC, Carter BW, Munden RF. The epidemiology of lung cancer. Transl Lung Cancer Res. 2018;7:220–233.30050761
  • Xu F, Xu P, Cui W, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios may aid and identifying patients with non-small cell lung cancer and predicting tumor-node-metastases stage. Oncol Lett. 2018;16:483–489.29928436
  • Wei L, Wu W, Han L, Yu W, Du Y. A quantitative analysis of the potential biomarkers of non-small cell lung cancer by circulating cell-free DNA. Oncol Lett. 2018;16:4353–4360.30250538
  • Sayan M, Kankoc A, Ozkan ND, et al. Simple peripheral blood cell parameters to predict prognosis in non-small cell lung cancer. Indian J Surg. 2020. doi:10.1007/s12262-020-02237-4
  • Sahin F, Aslan AF. Relationship between inflammatory and biological markers and lung cancer. J Clin Med. 2018;7. doi:10.3390/jcm7070160
  • Itazawa T, Tamaki Y, Komiyama T, et al. The Japan Lung Cancer Society–Japanese Society for Radiation Oncology consensus-based computed tomographic atlas for defining regional lymph node stations in radiotherapy for lung cancer. J Radiat Resp. 2017;58:86–105. doi:10.1093/jrr/rrw076
  • Detterbeck FC. The eighth edition TNM stage classification for lung cancer: what does it mean on main street? J Thorac Cardiovasc Surg. 2018;155:356–359.29061464
  • El-Sherif AH, Lau CT, Carter BW, Wu CC. Staging lung cancer: regional lymph node classification. Radiol Clin North Am. 2018;56:399–409. doi:10.1016/j.rcl.2018.01.00829622075
  • Wang L, Si H, Wang J, et al. Blood cell parameters as prognostic predictors of disease development for patients with advanced non-small cell lung cancer. Oncol Lett. 2020:20. doi:10.3892/ol2020.11655
  • Quiang G, Liang C, Xiao F, et al. Prognostic significance platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis. Onco Targets Ther. 2016;22:869–876. doi:10.2147/OTT.S96804
  • Yu Y, Qian L, Cui J. Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: a meta-analysis of 7219 patients. MolClinOncol. 2017;7:498–506.
  • Lan H, Zhou L, Chi D, et al. Preoperative platelet to lymphocyte and neutrophil to lymphocyte ratios are independent prognostic factors for patients undergoing lung cancer radical surgery: a single institution cohort study. Oncotarget. 2017;8:35301–35310. doi:10.18632/oncotarget.1331227845912
  • Diem S, Schmid S, Kraft M, et al. Neutrophil –to-lymphocyte ratio (NLR) and Platelet-to-lymphocyte ratio (PLR) as a prognostic markers in patients in non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 2017;111:176–181. doi:10.1016/j.lungcan.2017.07.02428838390
  • Huang Q, Diao P, Li C-L, et al. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to the other systemic inflammatory response markers in non-small cell lung cancer. Medicine. 2020:99. doi:10.1097/DM000000000001860732264914
  • Lee MB, Rodrigeuz A, Mena G, et al. Platelet-to-lymphocyte ratio and use of NSIADs during perioperative period as prognostic indicators in patients with NSCLC undergoing surgery. Cancer Control. 2016;23:284–294. doi:10.1177/10732748160230031227556669
  • Toda M, Tsukioka T, Isumi N, et al. Platelet-to-lymphocyte ratio predict the prognosis of patient with non-small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy. Thorac Cancer. 2018;9:112–119. doi:10.1111/1759-7714.1254729105365

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.